Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Marshall University Joan C. Edwards School of Medicine

3 abstracts

Abstract
The population-based effects of the FDA’s approval of durvalumab as consolidative therapy in patients with locally-advanced non-small cell lung cancer.
Org: Huntington, WV, Presbyterian University Hospital, Saint Mary's Medical Center, Marshall University Joan C. Edwards School of Medicine,
Abstract
Analysis of pathological complete response (PCR) and impact of modifiable risk factors on the premature discontinuation of pertuzumab use in early stage HER-2 breast cancer: A retrospective single-institutional study.
Org: Marshall University School of Medicine, Edwards Cancer Center, Marshall University Joan C. Edwards School of Medicine,
Abstract
Outcome analysis of immunotherapy and possible prognostic role of pretreatment neutrophil-lymphocyte ratio in lung cancer: An Appalachian study.
Org: Marshall University School of Medicine, Edwards Cancer Center, Marshall University Joan C. Edwards School of Medicine, Edwards Comprehensive Cancer Center, Joan C. Edwards College of Medicine,